Chicago Biosolutions Inc.

Chicago, IL

UEI
KJL4YQ7KSEK9
CAGE
7FKR0
Primary NAICS
Not on record
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
2242 W Harrison St #201, Chicago, IL 60612, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Development of 4-(aroylamino)piperidine-based entry inhibitors as anti-influenza therapeutics - influenza a viruses… R42AI155039 National Institute of Allergy and Infectious Diseases (NIH) $6,896,079
Furopyrimidines as novel inhibitors of henipaviruses - the emergence and reemergence of pathogenic viruses represent… R41AI157095 National Institute of Allergy and Infectious Diseases (NIH) $1,498,119
Development of group 2 influenza a virus entry inhibitors R41AI145727 National Institute of Allergy and Infectious Diseases (NIH) $599,998
Furopyrroles as novel anti-ebola agents R43CK000495 Office of Financial Resources (CDC) $225,000
4-(aminomethyl) benzamides as novel anti-ebola agents R42AI126971 National Institute of Allergy and Infectious Diseases (NIH) $4,881,299

Latest 5 listed here. See the rest on GovTribe.

Quick answers

Is Chicago Biosolutions Inc. registered in SAM.gov?

Yes. Chicago Biosolutions Inc.'s SAM.gov registration is active through February 25, 2027.

What is Chicago Biosolutions Inc.'s most recent federal award?

Chicago Biosolutions Inc.'s most recent federal grant award is Development of 4-(aroylamino)piperidine-based entry inhibitors as anti-influenza therapeutics - influenza a viruses… (R42AI155039), from National Institute of Allergy and Infectious Diseases (NIH), on April 2, 2021.

On GovTribe

See Chicago Biosolutions Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login